ArticleThe journal of prevention of Alzheimer's disease2026

Clarity AD open-label extension data do not robustly confirm disease course modification by lecanemab in ApoE

Jemma Hazan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.